News

Latest news

Cellaion SA announces an additional closing of 5,5M Euros financing on June 13th 2023.

Exciting News: NBC2’s new Portfolio Company, SANTERO Featured on Leading Media Outlets!

Exciting news! Our Senior Partner, Philippe De Backer, had the honour of speaking at the European Parliament on June 7 alongside Commissioner Thierry Breton.

We are delighted to share that on June 14, Dr Michihiko Wada, a specially appointed professor at the Clinical and Translational Research Center, Keio University Hospital 慶應義塾大学病院, and Mr Tatsufumi Aoyama, Chief Economist at Development Bank of Japan Inc.

We are thrilled to announce that our CEO, Alain Parthoens Parthoens, was recently featured in an article by Nikkei Biotechnology & Business discussing the FDA approval of Ogeda/Astellas' groundbreaking hot flash treatment.

Sequana Medical wins Best Technology Award for alfapump® at European Mediscience Awards

SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance.

Acticor Biotech: progress in discussions with EU and US Regulatory Agencies

Cellaion SA announces the arrival of Walid Abi-Saab in its Board of Directors, the hiring of Griet Goddemaer to lead clinical development and the green light from the DSMB for the continuation of ACLF- Dheliver Clinical trial.

2
3
4
5
6